The papers, published between 2015 and 2017, are from researchersbased at the Council of Scientific & Industrial Research (CSIR)–National Institute for Interdisciplinary Science and Technology (NIIST) in Thiruvananthapuram, India. S. Nishanth Kumar is the only author in common to all four paper and a corresponding on two of them; Dileep Kumar, a scientist at CSIR, is a corresponding author on three of the papers.
A journal is investigating research by a group in Australia, after receiving “serious allegations” regarding a 2017 paper about treating eye burns.
The journal, Frontiers in Pharmacology, has issued an expression of concern (EOC) for the 2017 paper while it investigates. The notice does not specify the nature of the allegations. Meanwhile, several other papers by the three researchers, based at Deakin University in Geelong, Australia, have also come under scrutiny. Late last month, Frontiers in Pharmacology retracted a 2015 paper by Kislay Roy, Rupinder Kanwar, and Jagat R Kanwar, citing image duplication. A 2015 paper in Biomaterials received a correction in May 2017, again flagging image duplication.
Roy, the first author on the papers, is a postdoctoral research fellow; Rupinder Kanwar, a middle author, is a senior lecturer; and Jagat R Kanwar, the corresponding author on all three, is head of the Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research.
Gearóid Ó Faoleán, the ethics and integrity manager at Frontiers in Pharmacology, explained that the investigation into the flagged article is ongoing and the EOC “must serve as the extent of our public statement for the present.”
Multiple investigations have been launched into allegations of blatant duplications by a research group in Malaysia.
Last week, users alleged on Twitter that three papers by the same team included pictures of cells that were copied and pasted. First author Nima Samie, affiliated with University of Malaya in Malaysia, denied the accusations — but both the Malaysian government and now two journals sees cause for further investigation.
Against the authors’ wishes, a pharmacology journal has retracted a paper after receiving two messages questioning the “soundness of the experimental results.”
The editors of the journal, Frontiers in Pharmacology,issued an expression of concern about the paper in April 2016, and investigated it following the allegations. According to the retraction notice, the authors disagree with the retraction.
Frontiers in Pharmacology has retracted a paper on baicalin, an antioxidant sold in health food stores, because it had both “incorrect data and invalid statistical analyses.”
A comment on PubPeer notes that one of the figures (see image to the right) contains two similar-looking flow cytometry images labeled with different values, which could be what the retraction is hinting at.